Aspirin boosts schizophrenia treatments, study shows
Some anti-inflammatory drugs such as aspirin, estrogen and the antioxidant Fluimucil (N-acetylcysteine) can improve the efficacy of existing schizophrenia treatments, new research shows.
Read MoreSome anti-inflammatory drugs such as aspirin, estrogen and the antioxidant Fluimucil (N-acetylcysteine) can improve the efficacy of existing schizophrenia treatments, new research shows.
Read MoreLocal Health Boards in Wales must be held to account for delivering the government’s Cancer Delivery Plan, politicians have urged, and they also warn that, without “stronger national leadership,” the Plan’s goals may not be met.
Read MoreThe European Medicines Agency says it is open to discussing the use of complementary evidence sources and methodologies with developers of potential treatments for rare cancers, for which large-scale clinical trials are frequently impossible.
Read MoreUlcerative colitis patients who have had a colectomy continue to experience symptoms, and 46% say that if they could go back in time, they would want more information on the treatment choices, according to a new patient survey.
Read MoreCritics of plans by European Commission President-elect Jean-Claude Juncker to remove oversight for the European Medicines Agency from the Commission’s Health and Consumer Directorate and give it to the Enterprise Directorate have welcomed reports that this move will not now take place.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
